Development History


2025

In August, we obtained OECD GLP certification from the Organisation for Economic Co-operation and Development (OECD), filling a gap in international qualifications within the northwest China biopharmaceutical industry chain.

2024

In July, we obtained the National Medical Products Administration’s drug GLP qualification (re-certification and scope expansion). In September, we obtained the Ministry of Agriculture and Rural Affairs’ veterinary drug GCP qualification (scope expansion) and submitted an application for OECD GLP certification (for veterinary drugs).

2023

In May, we obtained the “Good Laboratory Practice (GLP) Compliance Certificate” from the China National Accreditation Service for Conformity Assessment (CNAS). In December, we received the Veterinary Drug GCP Qualification from the Ministry of Agriculture and Rural Affairs.

2022

In August, we obtained the veterinary drug GLP qualification from the Ministry of Agriculture and Rural Affairs, launched the operation of the veterinary drug GCP system, and conducted simulation trials.

2021

In July, we obtained the Drug GLP qualification from the National Medical Products Administration, filling a gap in Shaanxi Province. In August, we submitted applications for Veterinary Drug GLP and CNAS GLP certifications.

2020

In January, we will operate the GLP system (MOA GLP [Veterinary Drugs]) and conduct simulation experiments.

2019

In August, we obtained the Shaanxi Province License for the Use of Experimental Animals and the Shaanxi Province CMA Accreditation.

2018

In November, Guorui Yinuo was established and began designing and renovating its facilities according to GLP laboratory standards. It secured angel-round investment from Xixian New Area Venture Capital Co., Ltd. and Xixian New Area Airport Innovation Industry Investment Partnership (Limited Partnership).

< 1 >